Site Logo
  1. Home
  2. Past Issues
  3. Summary Vol.84 Issue 1 / 2021
  4. Article
Letters
Visualizações

Arq. Bras. Oftalmol. 2021; 84 (1): 10.5935/0004-2749.20210012

Total: 2939

Lacrimal gland atrophy and dry eye related to isotretinoin, androgen, and prolactin: differential diagnosis for Sjögren’s syndrome

Amanda Pires Barbosa1; Fabíola Reis de Oliveira2; Flavio Jaime da Rocha3; Valdair Francisco Muglia2; Eduardo Melani Rocha1

DOI: 10.5935/0004-2749.20210012

1. Department of Ophthalmology, Otorhinolaryngology and Head & Neck Surgery, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
2. Department of Medicine, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil
3. Department of Ophthalmology, Faculdade de Medicina de Uberlândia, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil

Corresponding author

Eduardo Melani Rocha
E-mail: [email protected]

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.


Print PDF English
Open Access
Share

How to cite this article:

Barbosa AP, Oliveira FR, Rocha FJ, Muglia VF, Rocha EM. Atrofia das glândulas lacrimais e olho seco relacionados aisotretinoína, androgênio e prolactina: diagnóstico diferencial com a síndrome de Sjögren. Arq. Bras. Oftalmol. 2021;84(1):. 10.5935/0004-2749.20210012
Export citation